(Q40243654)

18 September 2017

Loss of oncostatin M receptor beta in metastatic melanoma cells (English)

1 reference

18 September 2017

1 reference

Lacreusette A

1

1 reference

18 September 2017

Nguyen JM

2

1 reference

18 September 2017

Pandolfino MC

3

1 reference

18 September 2017

Khammari A

4

1 reference

18 September 2017

Dreno B

5

1 reference

18 September 2017

Jacques Y

6

1 reference

18 September 2017

Godard A

7

1 reference

18 September 2017

Blanchard F

8

1 reference

18 September 2017

language of work or name

English

0 references

publication date

7 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

26

1 reference

18 September 2017

6

1 reference

18 September 2017

881-892

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209844

18 September 2017

0 references

cites work

Histone deacetylase inhibitors: new drugs for the treatment of inflammatory diseases?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Epitope-function relationships of human leukemia inhibitory factor receptors using a novel set of anti-gp190 mAB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

DNA methylation controls the responsiveness of hepatoma cells to leukemia inhibitory factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Interleukin-6-resistant melanoma cells exhibit reduced activation of STAT3 and lack of inhibition of cyclin E-associated kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Histone deacetylase inhibitors and malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

The role of STATs in transcriptional control and their impact on cellular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Histone acetylation-mediated regulation of genes in leukaemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Melanoma genetics and the development of rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Null leukemia inhibitory factor receptor (LIFR) mutations in Stuve-Wiedemann/Schwartz-Jampel type 2 syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

The oncostatin M signalling pathway: reversing the neoplastic phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Real-time allele-specific amplification for sensitive detection of the BRAF mutation V600E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Targeting STAT3 affects melanoma on multiple fronts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Antitumor activity of recombinant interleukin 6 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Roles of activated Src and Stat3 signaling in melanoma tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

The designer cytokine hyper-IL-6 mediates growth inhibition and GM-CSF-dependent rejection of B16 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

A new mathematical model for relative quantification in real-time RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Oncostatin M, a multifunctional cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Interferon-resistant human melanoma cells are deficient in ISGF3 components, STAT1, STAT2, and p48-ISGF3gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

On the road to a tumor cell vaccine: 20 years of cellular immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Histone deacetylase as a new target for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Stat3 dimerization regulated by reversible acetylation of a single lysine residue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

Modulation of LIF expression in human melanoma cells by oncostatin M

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

7 January 2021

Oncostatin M and interleukin 6 inhibit cell cycle progression by prevention of p27kip1 degradation in HepG2 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

7 January 2021

Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

7 January 2021

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

7 January 2021

Histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

7 January 2021

Genetically modified tumour vaccines (GMTV) in melanoma clinical trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

7 January 2021

Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209844

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209844

1 reference

Dimensions Publication ID

18 September 2017

0 references

1 reference